<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03124758</url>
  </required_header>
  <id_info>
    <org_study_id>TR24577-TP15879-TP14065</org_study_id>
    <nct_id>NCT03124758</nct_id>
  </id_info>
  <brief_title>Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by
      comparison to hemoglobin measurements from a laboratory hematology analyzer. Blood samples
      are collected from healthy volunteers who are enrolled in either a blood draw procedure or a
      hemodilution procedure wherein blood is repeatedly sampled as the concentration of hemoglobin
      is reduced in a controlled manner by administering fluids intravenously.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 20, 2010</start_date>
  <completion_date type="Actual">October 31, 2011</completion_date>
  <primary_completion_date type="Actual">October 31, 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of Sensor by Arms Calculation</measure>
    <time_frame>1-5 hours</time_frame>
    <description>Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">354</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Noninvasive Hemoglobin Sensor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects are enrolled into the test group and all subjects received the Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI, DCIP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemoglobin Sensor ((Rainbow Reusable DCI, DCIP))</intervention_name>
    <description>Measurement of Noninvasive Hemoglobin (SpHb)</description>
    <arm_group_label>Noninvasive Hemoglobin Sensor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        A. Hemodilution Test Procedure

        Inclusion Criteria:

          -  Weight of more than 110 lbs and less than 220 lbs.

          -  Physical status of ASA I of II

          -  Able to read and communicate in English

          -  Has signed written informed consent

          -  Female, non pregnant. Female subjects will be provided with a pregnancy test free of
             charge.

        Exclusion Criteria

          -  Age less than 18 yrs and greater than 35 years

          -  Weight of less than 110 lbs or more than 220 lbs.

          -  Hemoglobin less than 12 g/dL

          -  ASA physical status of III. IV, V.

          -  Pregnant

          -  Subject has known drug or alcohol abuse

          -  Subject has skin abnormalities affecting the digits such as psoriasis, eczema,
             angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish
             or acrylic nails.

          -  Subject has experienced a head injury with loss of consciousness within the last year

          -  Subject has known neurological and psychiatric disorder that interferes with the
             subjects level of consciousness

          -  Known or concurrent chronic usage of psychoactive or anticonvulsive drugs within the
             last 90 days, or any use in the last 7 day (i.e. tricyclic antidepressants, MAO
             inhibitors, Lithum, neuroleptics, anxiolytics or antipsychotics, except SSRIs).

          -  Subject has any medical condition which in the judgment of the investigator, renders
             them inappropriate for participation in this study, such as Reynauds Syndrome.

          -  Hypertension: Systolic BP &gt;140 mmHg or Diastolic BP &gt; 90 mmHg.

          -  Baseline heart rate &lt; 50 bpm.

          -  Inability to tolerate sitting still or minimal movement for up to 90 minutes

          -  Discretion of investigator

        B. Blood Draw Test Procedure

        Inclusion Criteria:

        -Subjects must understand and consent to be in the study.

        Exclusion Criteria

          -  Subjects less than 18 years of age.

          -  Subjects who do not understand the study and the risks involved.

          -  Anyone deemed ineligible by test personnel.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Masimo Corporation</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <results_first_submitted>May 8, 2017</results_first_submitted>
  <results_first_submitted_qc>May 8, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 6, 2017</results_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Noninvasive Hemoglobin Sensor</title>
          <description>All subjects are enrolled into the test group and all subjects received the Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI, DCIP)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="354"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="354"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Noninvasive Hemoglobin Sensor</title>
          <description>All subjects are enrolled into the test group and all subjects received the Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI, DCIP)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="354"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="354"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="127"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Accuracy of Sensor by Arms Calculation</title>
        <description>Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.</description>
        <time_frame>1-5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Noninvasive Hemoglobin Sensor</title>
            <description>All subjects are enrolled into the test group and all subjects received the Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI, DCIP)</description>
          </group>
        </group_list>
        <measure>
          <title>Accuracy of Sensor by Arms Calculation</title>
          <description>Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.</description>
          <units>g/dL</units>
          <param>Number</param>
          <units_analyzed>data points</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="354"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>data points</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1990"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Noninvasive Hemoglobin Sensor</title>
          <description>All subjects are enrolled into the test group and all subjects received the Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI, DCIP)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="354"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tala Harake</name_or_title>
      <organization>Masimo</organization>
      <email>studies@masimo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

